• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

Apronal Inhibitor

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5754528

Apronal (Allylisopropylacetylurea, Apronalide) is a hypnotic and sedative drug. It has been withdrawn in several countries due to side effects. More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
Apronal, Inhibitor
Full Product Name
Apronal
Product Synonym Names
Allylisopropylacetylurea; Apronalide
Form/Format
Solid. Powder
Purity/Purification
98.00%
Preparation and Storage
Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent
Molecular Weight
184.24
Solubility
DMSO: 165mg/mL (895.57mM)
(<1mg/ml refers to the product slightly soluble or insoluble)
Formula
C9H16N2O2
SMILES
C=CCC(C(C)C)C(NC(N)=O)=O
CAS Number
528-92-7
Target & IC50
Others
In Vitro
Research shows that allylisopropylacetylurea increases the amount of porphyrins in the liver and urine of animals. And it brings about a marked green pigmentation of the liver. Lesions originated by long-term administration with allylisopropylacetylurea can be tolerated by rats and are reversible[1]. Rats recover well from long-term treatment with high doses of allylisopropylacetylurea and revert to normal values for parameters measured. Fixed drug eruption and mucocutaneous ocular syndrome are reported due to apronal[2].

Structure of Apronal, inhibitor

Apronal Inhibitor – Cat# MBS5754528

Product References and Citations for Apronal, inhibitor

Rentsch G, et al. The effect of prolonged administration of allylisopropylacetylurea to rats on cytochrome P-450 and other liver haemoproteins. Xenobiotica. 1976 Mar;6(3):151-7.
Rentsch G, et al. The effect of prolonged administration of allylisopropylacetylurea to rats on cytochrome P-450 and other liver haemoproteins. Xenobiotica. 1976 Mar;6(3):151-7.
Fujimoto Y, et al. Fixed drug eruption due to allylisopropylacetylurea. Contact Dermatitis. 1993 May;28(5):282-4.
Fujimoto Y, et al. Fixed drug eruption due to allylisopropylacetylurea. Contact Dermatitis. 1993 May;28(5):282-4.

Other Notes

Small volumes of Apronal, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for Apronal purchase

MBS5754528 is an inhibitor targeting Apronal.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000